MENU
DMRA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Damora Therapeutics (DMRA) Earnings Date & Reports

Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders... Show more

A.I. Advisor
published Earnings

DMRA is expected to report earnings to rise 21.56% to -47 cents per share on October 30

Damora Therapeutics DMRA Stock Earnings Reports
Q3'26
Est.
$-0.47
Q2'26
Beat
by $0.05
Q1'26
Missed
by $0.30
Q4'25
Missed
by $135.47
The last earnings report on August 10 showed earnings per share of -38 cents, beating the estimate of -43 cents. With 77.19K shares outstanding, the current market capitalization sits at 1.90B.
View a ticker or compare two or three
DMRA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details